Hinge Bio, Inc.
BURLINGAME, CA · Founded 2015 · CIK 0001804959 · Medtech
Blood biomarker diagnostic test for Alzheimer's disease using flexible-hinged bispecific antibody beads and mass spectrometry to detect amyloid-beta
hingebio.com →- Grants
- $674K
- 3 awards
- Sector median: 1
- Raised
- $59M
- 3 Form D · Jan 2025
- 21 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 0 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Flex-Hinge Bispecific Antibodies for Ultra-Sensitive Detection of Beta Amyloid Species in Plasma | $224,683 | |
| Federal grant | Department of Health and Human Services · Phase I · Flex Hinge Bispecific Antibodies for Ultra Sensitive Detection of Beta Amyloid Species in Plasma | $224,683 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Highly Specific Flex-Hinge Antibody-Like Checkpoint Inhibitors for Safer and More Effective Cancer Therapy | $224,455 | |
| Private capital raised | Form D · SEC | $18,191,739 | |
| Private capital raised | Form D · SEC | $10,287,000 | |
| Private capital raised | Form D · SEC | $30,596,388 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 914 | DOMICELL INC. | — | — |
| 915 | CREATHADH ENERGIES, LLC | — | — |
| 916 | ORTHOCARE INNOVATIONS, LLC | — | $6.0M |
| 917 | Hinge Bio, Inc. | — | $59M |
| 918 | C4 IMAGING, LLC | — | $6.0M |
| 919 | Granite Medical, LLC | — | — |
| 920 | LungLife AI, Inc. | — | $53M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Daniel CaponDirector · Executive Officer
- Malcolm GefterDirector
- Jeffrey Long-McGieDirector
- J. PetkevichDirector
- John PetkevichDirector
- Carin RollinsDirector · Executive Officer
- Samuel SaksDirector
- Harold Selick, PhDDirector · Executive Officer
- Miriam SiekevitzExecutive Officer
- Alex SilversteinDirector
- William UngerDirector
Patents
- A CD19/CD20 Bispecific Antibody With Dual Fc Domainsapplication
- Tetrahedral Constructs Binding Folate And CD3application
- CD19/CD20 Bispecific Antibody with Dual Fc Domainsapplication
- Tetrahedral Constructs Binding Folate And CD3application
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.